Sprint Bioscience Ab Stock Profit Margin
| SPRINT Stock | SEK 0.69 0.04 5.48% |
Sprint Bioscience AB fundamentals help investors to digest information that contributes to Sprint Bioscience's financial success or failures. It also enables traders to predict the movement of Sprint Stock. The fundamental analysis module provides a way to measure Sprint Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sprint Bioscience stock.
Sprint |
Sprint Bioscience AB Company Profit Margin Analysis
Sprint Bioscience's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Sprint Bioscience AB has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Specialty & Generic industry. The profit margin for all Sweden stocks is 100.0% lower than that of the firm.
Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Sprint Fundamentals
| Return On Equity | -1.09 | |||
| Return On Asset | -0.59 | |||
| Operating Margin | (76.00) % | |||
| Current Valuation | 24.98 M | |||
| Shares Outstanding | 69.8 M | |||
| Shares Owned By Insiders | 35.31 % | |||
| Shares Owned By Institutions | 2.59 % | |||
| Price To Earning | 32.79 X | |||
| Price To Book | 2.61 X | |||
| Price To Sales | 27.09 X | |||
| Revenue | 35.11 M | |||
| Gross Profit | 24.59 M | |||
| EBITDA | (24.22 M) | |||
| Net Income | (25.08 M) | |||
| Cash And Equivalents | 13.82 M | |||
| Cash Per Share | 1.19 X | |||
| Debt To Equity | 32.20 % | |||
| Current Ratio | 2.69 X | |||
| Book Value Per Share | 0.63 X | |||
| Cash Flow From Operations | (40.12 M) | |||
| Earnings Per Share | (0.75) X | |||
| Target Price | 32.0 | |||
| Number Of Employees | 34 | |||
| Beta | 1.32 | |||
| Market Capitalization | 53.17 M | |||
| Total Asset | 79.14 M | |||
| Retained Earnings | (39 M) | |||
| Working Capital | 4 M | |||
| Current Asset | 25 M | |||
| Current Liabilities | 21 M | |||
| Net Asset | 79.14 M |
About Sprint Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sprint Bioscience AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sprint Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sprint Bioscience AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Sprint Stock
Sprint Bioscience financial ratios help investors to determine whether Sprint Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sprint with respect to the benefits of owning Sprint Bioscience security.